Mukka Proteins Limited has informed the Exchange regarding a press release dated May 16, 2026, titled "Mukka Proteins Limited Reports Strong FY26 PerformanceSustained Growth Momentum with Strategic Expansion".
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mukka Proteins Limited reported robust FY26 results with revenue of ₹1,449.5 crore, up 44% YoY, driven by strong global fishmeal demand and improved pricing. EBITDA grew 30.9% to ₹145.3 crore while PAT increased 18.7% to ₹57.1 crore. Q4 FY26 showed EBITDA margin expansion of 421 basis points YoY to 12.9%, with PAT up 52.6% YoY. Key strategic moves include a new Oman facility (21,249 sq mt), entry into Sri Lanka via Lanka Bio Proteins Private Limited, and a Bengaluru waste management contract with BBMP. The company also received MarinTrust Improver Programme certification, strengthening its sustainable sourcing credentials.
Strong topline growth and margin expansion signal operational efficiency gains and favorable industry conditions. New capacity expansions and geographic diversification could drive future revenue growth, though margin pressures from cost investments need monitoring.